formation of β-TCP at 800 C, whereas no such peak occurred in HA even up to
1000 C. In contrast, the substitution like Eu and F resulted in an increased thermal
stability. Similarly, Si substitution and K and Si co-substitution resulted in an enhanced
thermal stability in comparison with stoichiometric HA (Table 23.7). Zn and F
co-substitution in HA resulted in a decreased thermal stability with a total weight loss
of 25.09%. Co-substitution of strontium and fluorine in HA enhanced its thermal
stability. Only 7.56% total weight loss occurred in SrFHA nanopowders. MgSrHA
nanopowder exhibited only 1.8% weight loss after 700 C indicating its higher thermal
stability than MgHA. Among all the as-synthesized nanopowders, MgSrFHA
nanopowder exhibited highest thermal stability with a total weight loss of 5.28%.
23.5.4 Surface Area of Novel Hydroxyapatites
The novel hydroxyapatites have potential application as implants, and therefore their
mechanical properties are important, and these depend on the porosity of powders.
The BET surface area of nanopowders was evaluated by N2 adsorption using
Quantachrome Instruments NOVA 2200e Surface Area Analyzer employing
Brunauer-Emmett-Teller (BET) method (Joseph and Tanner 2005). The BET equa-
tion in linearized form is expressed as:
p
v p0 p
ð
Þ ¼ 1
vmz þ z 1
vmz
p
p0
ð23:6Þ
where z is a constant related to energy of adsorption, p/p0 is the relative vapor
pressure of adsorbate, v is the volume of gas adsorbed, and vm is the volume of gas
adsorbed in a monolayer. The minimum resolution for p/p0 was 2 105. A linear
regression of the left side of the BET equation and p/p0 yielded a slope and intercept
from which z and vm were obtained. Table 23.8 presents the BET surface area of
nanopowders as calculated from vm (Currey 2005). Interestingly, ionic substitution
lowered the surface area of HA nanopowders, indicating that substituted
hydroxyapatites are denser than stoichiometric HA. The order of the BET surface
area of nanopowders is as follows:
HA > ZnHA > FHA > SrFHA > MgHA > KSiHA > SiHA > MgSrFHA
> MgSrHA
23.5.5 Bioactivity of Novel Hydroxyapatites
In vitro bioactivity estimation of nanopowders was performed in a simulated body
fluid (SBF). The various reagents used in the preparation of SBF are given in
Table
23.9.
SBF
has
ionic
composition
matching
human
blood
plasma
(Table 23.10).
23
Unleashing Potential of Bone Mimicking Nanodimensional Hydroxyapatites and. . .
443